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From April 15 to 18 of this year, we are pleased to host the third joint
meeting of the European Society for Microcirculation (ESM)1 and the
European Vascular Biology Organization (EVBO)2 in Maastricht
(Figure 1A). The conference draws research scientists, investigators in ba-
sic and applied research, clinicians, post-doctoral fellows, and graduate
students actively engaged in the growing fields of microcirculation and
vascular biology. The conference objective is to advance research and
education in the many areas of microcirculation and vascular biology.
History of joint meetings
As the fields of expertise of the members of these two societies are linked
and often overlapping, both boards conceived the idea of organizing a joint
meeting. Clearly, there are many benefits for basic science societies to join
forces related to scientific crosstalk to generate new ideas, link two net-
works as an opportunity for both young and established researchers, and
be financially sustainable. Hence, the Maastricht meeting already represents
the third joint meeting of these two societies. The first meeting was held in
Pisa in 2015 and organized by Profs. Marco Rossi and Jozef Dulak. After a
successful meeting with high-quality abstracts3 and active scientific discus-
sions, Prof. Beat Imhof took it upon himself to organize the second one in
Geneva in 2017, together with local organizers Prof. Bochaton-Piallat, and
Dr Kwak. This became a wonderful homage to his scientific work, and in-
teresting data and 187 abstracts were presented.4 Although the majority
of delegates work in Europe, there was representation from North
America, Australia, and Asia, as shown by an overview of the 28 different
nationalities of delegates attending the previous conference in 2017
(Figure 1B). Prof. Beat Imhof first introduced the young investigator session,
as a platform for recently established group leaders to show their excellent
research. This was very well received, and offers an outstanding chance to
young investigators, for whom it is imperative, yet challenging to ascertain
invited lectures. We will continue this admirable idea also in Maastricht.
This year’s programme
The Dutch organizers, Dr Alfons (Boy) Houben (CARIM/MUMCþ
Maastricht), Dr Judith Sluimer (CARIM/MUMCþ Maastricht), Prof. Jaap
van Buul (Sanquin, VUMC, Amsterdam), Dr Ed Eringa (VUMC,
Amsterdam), Dr Stephan Huveneers (AMC, Amsterdam), and Dr Guido
Krenning (UMCG, Groningen) aimed to design a programme satisfying
both basic and clinical scientists. As board members of the Dutch
Endothelial cell Biology Society (DEBS), and Microcirculation & Vascular
Biology MiVaB societies, they have organized joint meetings in The
Netherlands since 2010 and will even officially join forces as the
Netherlands Vascular Biology Organization (NeVBO). Hence, the team
is suited to organize this joint meeting. With strong representation from
the International Scientific Advisory Committee5 and ESM and EVBO
boards,1,2 the Organizing Committee have developed an exciting pro-
gramme which reflects the growing research areas of vascular cell biol-
ogy, microcirculation and their related diseases, while also highlighting
new technologies, such as single cell sequencing.6
The scientific programme revolves around the themes of the physiol-
ogy and pathology of small and large blood vessels. Main and concurrent
sessions will focus on (lymph) angiogenesis, vascular pathologies, vascular
cell function, and their progenitors, heterogeneity and clonal expansion,
vascular ageing and drug targeting, micro- and macrovascular pathologies
in cardiometabolic and neurovascular disease, and treatment thereof. The
conference is compliant with MedTech code and will secure Continuing
Medical Education accreditation.
Currently all five keynote speakers have accepted to showcase their past
and latest work on clinical microvascular function and cardiometabolic dis-
eases (Prof Coen Stehouwer, MUMC Maastricht), mechanobiology and en-
dothelial plasticity (Prof. Christopher Chen,), Leucocyte traffic and vascular
interactions (Prof. Christopher Scheierman, LMU, Germany), Vascular het-
erogeneity (Prof Christer Betsholtz, Karolinska, Sweden), and Clinical imag-
ing of vascular pathology (Prof. Dave Newby, University of Edinburgh, UK).
As mentioned, a young investigator symposium is organized by Prof.
Yvonne Alexander (Manchester UK); Dr Reinier Boon (AMC,
Amsterdam); Prof. Marion Graupera (IDIBELL, Barcelona), hosting Dr’s
Baer, de Bock, and Franco, Kaikkonen-Määttä, and Kusumbe. Moreover,
we are proud to announce that special lectures are funded by both
EVBO and ESM societies: including the EVBO medal lecture for lifetime
achievements by Prof Elisabetta Dejana, and the early career EVBO lec-
ture by Dr Rui Benedito. Nominations for the Malpighi lecture by ESM
and the Servier award for outstanding publication on microcirculation/
vascular biology research in the experimental or the clinical environment
are now being reviewed by ESM. We also welcome our colleagues from
the European Society of Cardiology (ESC) working group on
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..atherosclerosis and vascular biology, who have organized a symposium
on endothelial dysfunction. Finally, a new ESM working group will be
launched on Retinal Microvascular Research in human studies by Dr Boy
Houben and Prof. Henner Hanssen.
As one of our aims is to stimulate and educate early career scientists
(ECS), we composed a special programme for our young delegates, in-
cluding many workshops (meet the editor of Cardiovascular Research
Professor Tomasz Guzik, press communication, impact and valorization,
non-invasive, and mass spectrometry imaging), their own social pro-
gramme and preferred accommodation to stimulate new networks, and
we offer in total 19 travel fellowships and eight poster awards.7
Although we allocated 37 slots (42% of all conference presentations) for
oral presentations to have a training platform for ECS, this still only
meant a 13% chance to be selected for an oral presentation. To further
foster our early career scientists, future organizers could consider pre-
conference satellites organized for and by early career scientists to sup-
port their development, build networks and, importantly allow an even
larger podium for oral presentations.
Current facts and future meetings
As of February 1st 2019, we received 287 abstracts, surpassing the previ-
ous meetings by 50%. The international scientific committee reviewed
Figure 1 Logo and international community attending ESM-EVBO. (A) Conference logo. (B) Country of origin of 2017 delegates (pie chart 2017 dele-
gates). (C) Current national distribution of registered 2019 delegates (current as of January 2019).
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these, and abstract submitters will have been informed by the end of
February about acceptance and the type of presentation. Based on cur-
rent numbers, we anticipate over 400 delegates, and the scientific com-
munity scheduled to attend the meeting thus far, again consists of a
broad international community from 36 countries (Figure 1C). We are
welcoming. We sincerely wish to thank our sponsors and partners for
making this meeting possible.8 To remain informed on the programme,
news, and to register for our ECS workshops please follow us on social
media (@ESMEVBO2019), and check our website regularly (www.ESM-
EVBO2019.org).
What does the future hold? At the moment, a venue and organizer
for the 2021 meeting has yet to be selected; however, we sincerely hope
this tradition of joint meetings will also be continued in the future.
Conflict of interest: none declared.
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